{"id":1627,"date":"2026-06-27T11:17:43","date_gmt":"2026-06-27T09:17:43","guid":{"rendered":"https:\/\/egmond-circle.eu\/press\/"},"modified":"2026-08-17T14:51:41","modified_gmt":"2026-08-17T12:51:41","slug":"press","status":"publish","type":"page","link":"https:\/\/egmond-circle.eu\/en\/press\/","title":{"rendered":"Press"},"content":{"rendered":"<p><\/p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background fusion-parallax-none hundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--link_color: var(--awb-color8);--awb-background-position:right bottom;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:100px;--awb-padding-right:0px;--awb-padding-left:0px;--awb-margin-bottom:0px;--awb-background-color:var(--awb-color3);--awb-background-image:url(&quot;https:\/\/egmond-circle.eu\/wp-content\/uploads\/2026\/06\/bildmarke-hg-muster.svg&quot;);--awb-background-size:40vh;--awb-flex-wrap:wrap;\"><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"width:104% !important;max-width:104% !important;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-padding-right:25px;--awb-padding-bottom:80px;--awb-padding-left:25px;--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:30vw;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10vw;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:30vw;--awb-spacing-left-medium:10vw;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-row\"><div class=\"fusion-menu-anchor\" id=\"anfang\"><\/div><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-one kein-toc\" style=\"--awb-margin-bottom:50px;--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-font-size:36px;\"><h1 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;Inter-Light&quot;;margin:0;letter-spacing:0.025em;font-size:1em;--fontSize:36;line-height:1.25;\">\u201cEgmond Circle\u201d  \n<p><span style=\"font-size: smaller;\">Inter\u00adna\u00adtional Gath\u00ader\u00ading for People Affected by Contergan\/Thalidomide<\/span><\/p><\/h1><\/div><div class=\"fusion-text fusion-text-1\" style=\"--awb-font-size:var(--awb-typography3-font-size);--awb-line-height:var(--awb-typography3-line-height);--awb-letter-spacing:var(--awb-typography3-letter-spacing);--awb-text-transform:var(--awb-typography3-text-transform);--awb-text-font-family:var(--awb-typography3-font-family);--awb-text-font-weight:var(--awb-typography3-font-weight);--awb-text-font-style:var(--awb-typography3-font-style);\"><p>Vom 26. Okto\u00adber bis zum 2. Novem\u00adber 2026 findet in Egmond aan Zee das inter\u00adna\u00adtionale Begeg\u00adnungs\u00adfest \u201eEgmond Circle\u201c statt. Erwartet werden rund 300 G\u00e4ste aus verschiede\u00adnen L\u00e4ndern. Vortr\u00e4ge und Prax\u00adis\u00adwork\u00adshops greifen Themen auf wie Gesund\u00adheit und \u00c4lter\u00adw\u00ader\u00adden, medi\u00adzinis\u00adche Bedarfe, Hilf\u00ads\u00admit\u00adtel, Assis\u00adtenz, barri\u00adere\u00adfreies Wohnen und Mobil\u00adit\u00e4t. Beglei\u00adt\u00adend bietet die Woche zahlre\u00adiche Gele\u00adgen\u00adheiten f\u00fcr Kunst, Kultur und inter\u00adna\u00adtionalen Austausch.<\/p>\n<p>\u201eEgmond Circle\u201c bringt Menschen mit Contergan-\/Thalidomid\u00adsch\u00e4digung, ihre Ange\u00adh\u00f6ri\u00adgen sowie Wissen\u00adschaftler*innen und Unterst\u00fctzer*innen zusam\u00admen. Eine Woche lang geht es um Fragen des Lebens mit Contergan-\/Thalidomid\u00adsch\u00e4digung im Alter \u2013 im fach\u00adlichen Austausch ebenso wie in pers\u00f6n\u00adlichen Begegnungen.<\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\"><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-3 fusion-flex-container has-pattern-background has-mask-background hundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\"><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-justify-content-center fusion-flex-content-wrap\" style=\"width:104% !important;max-width:104% !important;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_2_3 2_3 fusion-flex-column\" style=\"--awb-padding-right:80px;--awb-padding-right-small:0px;--awb-bg-size:cover;--awb-width-large:66.666666666667%;--awb-margin-top-large:40px;--awb-spacing-right-large:2.88%;--awb-margin-bottom-large:100px;--awb-spacing-left-large:2.88%;--awb-width-medium:66.666666666667%;--awb-order-medium:0;--awb-spacing-right-medium:2.88%;--awb-spacing-left-medium:2.88%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:100px;width:100%;\"><\/div><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row fusion-flex-align-items-flex-start fusion-flex-justify-content-center fusion-flex-content-wrap\" style=\"--awb-min-height:undefined;--awb-min-height-medium:undefined;--awb-min-height-small:undefined;--awb-flex-grow:undefined;--awb-flex-grow-medium:undefined;--awb-flex-grow-small:undefined;--awb-flex-shrink:undefined;--awb-flex-shrink-medium:undefined;--awb-flex-shrink-small:undefined;width:104% !important;max-width:104% !important;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-0 fusion_builder_column_inner_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-border-color:var(--awb-custom_color_2);--awb-border-top:1px;--awb-border-style:solid;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"accordian fusion-accordian\" style=\"--awb-padding-top:8px;--awb-padding-bottom:10px;--awb-border-size:1px;--awb-icon-size:26px;--awb-content-font-size:var(--awb-typography4-font-size);--awb-icon-alignment:left;--awb-hover-color:var(--awb-color2);--awb-border-color:var(--awb-color3);--awb-background-color:var(--awb-color1);--awb-divider-color:var(--awb-custom_color_2);--awb-divider-hover-color:var(--awb-color3);--awb-icon-color:var(--awb-color7);--awb-title-color:var(--awb-color8);--awb-content-color:var(--awb-color8);--awb-icon-box-color:var(--awb-color8);--awb-toggle-hover-accent-color:var(--awb-color6);--awb-title-font-family:var(--awb-typography1-font-family);--awb-title-font-weight:var(--awb-typography1-font-weight);--awb-title-font-style:var(--awb-typography1-font-style);--awb-title-font-size:16px;--awb-content-font-family:var(--awb-typography4-font-family);--awb-content-font-weight:var(--awb-typography4-font-weight);--awb-content-font-style:var(--awb-typography4-font-style);\"><div class=\"panel-group fusion-toggle-icon-unboxed\" id=\"accordion-1627-1\"><div class=\"fusion-panel panel-default panel-6cfb8713ebc78e869 fusion-toggle-has-divider\" style=\"--awb-title-color:var(--awb-color8);--awb-content-color:var(--awb-color8);\"><div class=\"panel-heading\"><h2 class=\"panel-title toggle\" id=\"toggle_6cfb8713ebc78e869\"><a aria-expanded=\"false\" aria-controls=\"6cfb8713ebc78e869\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-1627-1\" data-target=\"#6cfb8713ebc78e869\" href=\"#6cfb8713ebc78e869\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon ec-icon-auge-geschlossen-2\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon ec-icon-auge-offen\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">\u201cEgmond Circle\u201d at a Glance<\/span><\/a><\/h2><\/div><div id=\"6cfb8713ebc78e869\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_6cfb8713ebc78e869\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p><strong>Event:<br><\/strong>Egmond Circle \u2013 Contergan\/Thalidomide<br>Remem\u00adber. Under\u00adstand. Think&nbsp;Ahead.&nbsp;<\/p>\n<p><strong>Date:<br><\/strong>From Octo\u00adber 26 to Novem\u00adber 2,&nbsp;2026<\/p>\n<p><strong>Loca\u00adtion:<br><\/strong>Hotel Zuider\u00adduin, Egmond aan Zee, Netherlands<\/p>\n<p><strong>Partic\u00adi\u00adpants:<br><\/strong>About 300 guests from many countries<\/p>\n<p><strong>Topics:<br><\/strong>Health and Aging, Medical Needs, Assis\u00adtive Devices, Personal Assis\u00adtance, Acces\u00adsi\u00adble Hous\u00ading, Mobil\u00adity, as well as Art, Culture, and Inter\u00adna\u00adtional Exchange<\/p>\n<p><strong>Languages and Acces\u00adsi\u00adbil\u00adity:<\/strong><br>The confer\u00adence language is German. Simul\u00adta\u00adne\u00adous inter\u00adpre\u00adta\u00adtion into English and Portuguese, as well as writ\u00adten and sign language inter\u00adpre\u00adta\u00adtion, will be provided.&nbsp;<\/p>\n<p><strong>Orga\u00adnizer:<br><\/strong>Asso\u00adci\u00ada\u00adtion of Thalido\u00admide Victims North Rhine-Westphalia e.V. (Inter\u00adessen\u00adver\u00adband Conter\u00adgangesch\u00e4di\u00adger Nordrhein-Westfalen e.V.) \u2013 Aid Orga\u00adni\u00adza\u00adtion for Those Affected by Prena\u00adtal Damage<\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-5cdeef6fed19e056c fusion-toggle-has-divider\" style=\"--awb-title-color:var(--awb-color8);--awb-content-color:var(--awb-color8);\"><div class=\"panel-heading\"><h2 class=\"panel-title toggle\" id=\"toggle_5cdeef6fed19e056c\"><a aria-expanded=\"false\" aria-controls=\"5cdeef6fed19e056c\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-1627-1\" data-target=\"#5cdeef6fed19e056c\" href=\"#5cdeef6fed19e056c\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon ec-icon-auge-geschlossen-2\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon ec-icon-auge-offen\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Topics from \u201cEgmond Circle\u201d<\/span><\/a><\/h2><\/div><div id=\"5cdeef6fed19e056c\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_5cdeef6fed19e056c\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>\u201cEgmond Circle\u201d combines expert infor\u00adma\u00adtion, prac\u00adti\u00adcal discus\u00adsion, and personal inter\u00adac\u00adtion. The focus is on topics that are partic\u00adu\u00adlarly impor\u00adtant for many people with thalidomide-related disabil\u00adi\u00adties&nbsp;today:&nbsp;<\/p>\n<p><strong>Health and Aging<br><\/strong>How do phys\u00adi\u00adcal demands change as we age? What medical ques\u00adtions arise? What kind of care is needed?&nbsp;<\/p>\n<p><strong>Aids and every\u00adday life<br><\/strong>Which assis\u00adtive devices make every\u00adday life easier? What solu\u00adtions have those affected come up with them\u00adselves? What support is needed regard\u00ading bath\u00adrooms, beds, mobil\u00adity or communication?&nbsp;<\/p>\n<p><strong>Assis\u00adtance and Care<br><\/strong>How can support be orga\u00adnized with\u00adout losing one\u2019s auton\u00adomy? What expe\u00adri\u00adences have there been with personal assis\u00adtance, supple\u00admen\u00adtal care, and inter\u00adna\u00adtional care systems?&nbsp;<\/p>\n<p><strong>Acces\u00adsi\u00adble Living<br><\/strong>What are the require\u00adments for apart\u00adments, bath\u00adrooms, doors, path\u00adways, and fixtures? Which modi\u00adfi\u00adca\u00adtions become partic\u00adu\u00adlarly impor\u00adtant as we&nbsp;age?&nbsp;<\/p>\n<p><strong>Mobil\u00adity and Vehi\u00adcle Modi\u00adfi\u00adca\u00adtions<br><\/strong>How can mobil\u00adity be main\u00adtained? What tech\u00adni\u00adcal solu\u00adtions are avail\u00adable? What expe\u00adri\u00adences do those affected have with vehi\u00adcle modi\u00adfi\u00adca\u00adtions and acces\u00adsi\u00adble routes?&nbsp;<\/p>\n<p><strong>Art, Culture, and Connec\u00adtion<br><\/strong>\u201cEgmond Circle\u201d is not just a profes\u00adsional event, but also a cele\u00adbra\u00adtion of connec\u00adtion. Art, culture, leisure, and shared expe\u00adri\u00adences create oppor\u00adtu\u00adni\u00adties for conver\u00adsa\u00adtion, reunions, and new connections.&nbsp;<\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-214cf38311e67c3f2 fusion-toggle-has-divider\" style=\"--awb-title-color:var(--awb-color8);--awb-content-color:var(--awb-color8);\"><div class=\"panel-heading\"><h2 class=\"panel-title toggle\" id=\"toggle_214cf38311e67c3f2\"><a aria-expanded=\"false\" aria-controls=\"214cf38311e67c3f2\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-1627-1\" data-target=\"#214cf38311e67c3f2\" href=\"#214cf38311e67c3f2\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon ec-icon-auge-geschlossen-2\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon ec-icon-auge-offen\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Why \u201cEgmond Circle\u201d?<\/span><\/a><\/h2><\/div><div id=\"214cf38311e67c3f2\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_214cf38311e67c3f2\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>Since child\u00adhood, people with thalidomide-related disabil\u00adi\u00adties have learned to compen\u00adsate for their phys\u00adi\u00adcal limi\u00adta\u00adtions through strength, move\u00adment patterns and assis\u00adtive devices. However, what has enabled them to live inde\u00adpen\u00addently for decades can often present new chal\u00adlenges in old age. Constant overuse of certain body parts can lead to increased pain, signs of wear and tear, fatigue, and psycho\u00adlog\u00adi\u00adcal stress&nbsp;<\/p>\n<h3>Issues Related to&nbsp;Aging<\/h3>\n<p>While the focus in the past was primar\u00adily on inte\u00adgra\u00adtion and partic\u00adi\u00adpa\u00adtion, issues related to aging are now increas\u00adingly taking center stage for people with thalidomide-related disabil\u00adi\u00adties. \u201cEgmond Circle\u201d provides a forum for ques\u00adtions that concern people with thalidomide-related disabil\u00adi\u00adties and their fami\u00adlies today: What medical care is needed? Which assis\u00adtive devices make daily life easier? How can assis\u00adtance, mobil\u00adity, hous\u00ading, and care be orga\u00adnized in a way that preserves self-determination?&nbsp;<\/p>\n<h3>International Dimension<\/h3>\n<p>The inter\u00adna\u00adtional dimen\u00adsion of the thalido\u00admide history is also a topic of discus\u00adsion at the \u201cEgmond Circle.\u201d The living situ\u00ada\u00adtions of those affected still vary greatly today, depend\u00ading on recog\u00adni\u00adtion proce\u00addures, health\u00adcare systems, medical infra\u00adstruc\u00adture, access to assis\u00adtive devices and soci\u00adetal percep\u00adtions. Inter\u00adna\u00adtional exchange enables knowl\u00adedge to be shared, expe\u00adri\u00adences to be high\u00adlighted, and common concerns to be articulated.&nbsp;<\/p>\n<h3>Exchange and Interaction<\/h3>\n<p>In addi\u00adtion, \u201cEgmond Circle\u201d is also an inter\u00adna\u00adtional gath\u00ader\u00ading where people can make new friends and recon\u00adnect with old ones, featur\u00ading a support\u00ading program of art and culture as well as shared recre\u00adational activ\u00adi\u00adties. Beyond shar\u00ading knowl\u00adedge and offer\u00ading guid\u00adance, the event is about remem\u00adbrance and recog\u00adni\u00adtion, strength\u00aden\u00ading soli\u00addar\u00adity, offer\u00ading encour\u00adage\u00adment, and \u2013 last but not least \u2013 cele\u00adbrat\u00ading the joy of&nbsp;life.&nbsp;<\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-d69a3764eaac11cff fusion-toggle-has-divider\" style=\"--awb-title-color:var(--awb-color8);--awb-content-color:var(--awb-color8);\"><div class=\"panel-heading\"><h2 class=\"panel-title toggle\" id=\"toggle_d69a3764eaac11cff\"><a aria-expanded=\"false\" aria-controls=\"d69a3764eaac11cff\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-1627-1\" data-target=\"#d69a3764eaac11cff\" href=\"#d69a3764eaac11cff\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon ec-icon-auge-geschlossen-2\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon ec-icon-auge-offen\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Accessibility and Multilingualism<\/span><\/a><\/h2><\/div><div id=\"d69a3764eaac11cff\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_d69a3764eaac11cff\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>To enable as many people as possi\u00adble to partic\u00adi\u00adpate, acces\u00adsi\u00adbil\u00adity and linguis\u00adtic acces\u00adsi\u00adbil\u00adity are key require\u00adments for \u201cEgmond Circle.\u201d<\/p>\n<p>Plans include, among other things:<\/p>\n<ul>\n<li>The confer\u00adence language is German; simul\u00adta\u00adne\u00adous inter\u00adpre\u00adta\u00adtion will be provided into English and Portuguese.<\/li>\n<li>Writ\u00adten Interpretation<\/li>\n<li>Sign Language Interpretation<\/li>\n<li>Support for special needs related to hous\u00ading, assis\u00adtive devices, and<\/li>\n<li>Care<\/li>\n<li>Infor\u00adma\u00adtion in multi\u00adple languages<\/li>\n<li>Infor\u00adma\u00adtion in Easy-to-Read Language<\/li>\n<\/ul>\n<p>Special needs are also taken into account when it comes to lodg\u00ading, travel, and the&nbsp;stay.<\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-90918a0fca75bb53e fusion-toggle-has-divider\" style=\"--awb-title-color:var(--awb-color8);--awb-content-color:var(--awb-color8);\"><div class=\"panel-heading\"><h2 class=\"panel-title toggle\" id=\"toggle_90918a0fca75bb53e\"><a aria-expanded=\"false\" aria-controls=\"90918a0fca75bb53e\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-1627-1\" data-target=\"#90918a0fca75bb53e\" href=\"#90918a0fca75bb53e\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon ec-icon-auge-geschlossen-2\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon ec-icon-auge-offen\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Interview Requests<\/span><\/a><\/h2><\/div><div id=\"90918a0fca75bb53e\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_90918a0fca75bb53e\"><div class=\"panel-body toggle-content fusion-clearfix\">For edito\u00adr\u00adial teams, inter\u00adview subjects can be arranged upon request, for exam\u00adple on the follow\u00ading topics:\n<ul>\n<li>Living with Thalidomide-Related Disabil\u00adi\u00adties in Old&nbsp;Age<\/li>\n<li>Health, Reha\u00adbil\u00adi\u00adta\u00adtion, and&nbsp;Care<\/li>\n<li>Assis\u00adtance, Assis\u00adtive Devices, and Inde\u00adpen\u00addent Daily Living<\/li>\n<li>Inter\u00adna\u00adtional Expe\u00adri\u00adences with Recog\u00adni\u00adtion and Support<\/li>\n<li>A Reminder of the Thalido\u00admide Scan\u00addal and Its Consequences<\/li>\n<li>Goals and Signif\u00adi\u00adcance of \u201cEgmond Circle\u201d<\/li>\n<li>Partic\u00adi\u00adpants\u2019 Personal Perspectives<\/li>\n<\/ul>\n<p>Please direct inter\u00adview requests to the press contact.<\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:30px;width:100%;\"><\/div><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row fusion-flex-align-items-flex-start fusion-flex-justify-content-center fusion-flex-content-wrap\" style=\"--awb-min-height:undefined;--awb-min-height-medium:undefined;--awb-min-height-small:undefined;--awb-flex-grow:undefined;--awb-flex-grow-medium:undefined;--awb-flex-grow-small:undefined;--awb-flex-shrink:undefined;--awb-flex-shrink-medium:undefined;--awb-flex-shrink-small:undefined;width:104% !important;max-width:104% !important;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-1 fusion_builder_column_inner_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-border-color:var(--awb-custom_color_2);--awb-border-top:1px;--awb-border-style:solid;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"accordian fusion-accordian\" style=\"--awb-padding-top:8px;--awb-padding-bottom:10px;--awb-border-size:1px;--awb-icon-size:26px;--awb-content-font-size:var(--awb-typography4-font-size);--awb-icon-alignment:left;--awb-hover-color:var(--awb-color2);--awb-border-color:var(--awb-color3);--awb-background-color:var(--awb-color1);--awb-divider-color:var(--awb-custom_color_2);--awb-divider-hover-color:var(--awb-color3);--awb-icon-color:var(--awb-color7);--awb-title-color:var(--awb-color8);--awb-content-color:var(--awb-color8);--awb-icon-box-color:var(--awb-color8);--awb-toggle-hover-accent-color:var(--awb-color6);--awb-title-font-family:var(--awb-typography1-font-family);--awb-title-font-weight:var(--awb-typography1-font-weight);--awb-title-font-style:var(--awb-typography1-font-style);--awb-title-font-size:16px;--awb-content-font-family:var(--awb-typography4-font-family);--awb-content-font-weight:var(--awb-typography4-font-weight);--awb-content-font-style:var(--awb-typography4-font-style);\"><div class=\"panel-group fusion-toggle-icon-unboxed\" id=\"accordion-1627-2\"><div class=\"fusion-panel panel-default panel-7794498005e69ef6c fusion-toggle-has-divider\" style=\"--awb-title-color:var(--awb-color8);--awb-content-color:var(--awb-color8);\"><div class=\"panel-heading\"><h2 class=\"panel-title toggle\" id=\"toggle_7794498005e69ef6c\"><a aria-expanded=\"false\" aria-controls=\"7794498005e69ef6c\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-1627-2\" data-target=\"#7794498005e69ef6c\" href=\"#7794498005e69ef6c\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon ec-icon-auge-geschlossen-2\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon ec-icon-auge-offen\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Background: What is Contergan\/Thalidomide?<\/span><\/a><\/h2><\/div><div id=\"7794498005e69ef6c\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_7794498005e69ef6c\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>Conter\u00adgan was a sleep aid and seda\u00adtive manu\u00adfac\u00adtured by Gr\u00fcnen\u00adthal that contained the active ingre\u00addi\u00adent thalido\u00admide. It was launched in the Federal Repub\u00adlic of Germany in Octo\u00adber 1957 as an over-the-counter medica\u00adtion and was taken as a \u201cmira\u00adcle pill\u201d for condi\u00adtions such as insom\u00adnia, anxi\u00adety, and morn\u00ading sick\u00adness, among others. At the time, adver\u00adtise\u00adments portrayed the drug as partic\u00adu\u00adlarly well-tolerated and&nbsp;safe.&nbsp;<\/p>\n<h3>Global Distribution of Thalidomide<\/h3>\n<p>Medica\u00adtions contain\u00ading thalido\u00admide were marketed inter\u00adna\u00adtion\u00adally under vari\u00adous brand names, includ\u00ading \u201cSoftenon,\u201d \u201cDistaval,\u201d and \u201cKevadon.\u201d In the U.S., however, Kevadon was not offi\u00adcially approved. In addi\u00adtion, some coun\u00adtries had thalidomide-containing prepa\u00adra\u00adtions that were not marketed by Gr\u00fcnen\u00adthal or its licens\u00ading and distri\u00adb\u00adu\u00adtion part\u00adners. In Brazil, thalido\u00admide was later used in partic\u00adu\u00adlar to treat the after\u00adef\u00adfects of leprosy.&nbsp;<\/p>\n<h3>Consequences of Use During Pregnancy<\/h3>\n<p>If women took thalido\u00admide during preg\u00adnancy, the active ingre\u00addi\u00adent could cause severe birth defects in the unborn child. Depend\u00ading on when during preg\u00adnancy the drug was taken, the arms and legs were often severely short\u00adened. Damage could also affect the ears, eyes, inter\u00adnal organs and other parts of the&nbsp;body.&nbsp;<\/p>\n<p>On Novem\u00adber 27, 1961, Gr\u00fcnen\u00adthal with\u00addrew Conter\u00adgan from the market in Germany. World\u00adwide, the number of people with thalidomide-related disabil\u00adi\u00adties is esti\u00admated at about 10,000; in Germany, the figure is around 5,000. More than 2,000 people affected by the drug live in Germany today.&nbsp;<\/p>\n<h3>Impact on Politics and Society<\/h3>\n<p>The Conter\u00adgan scan\u00addal had far-reaching conse\u00adquences for phar\u00adma\u00adceu\u00adti\u00adcal law. Follow\u00ading the disas\u00adter, the require\u00adments for the test\u00ading, approval, and safety of medica\u00adtions were signif\u00adi\u00adcantly tight\u00adened. At the same time, the scan\u00addal contin\u00adues to shape the debate to this day regard\u00ading respon\u00adsi\u00adbil\u00adity, compen\u00adsa\u00adtion, care, and self-determination for people with thalidomide-related disabilities.&nbsp;<\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-debabafcbe112094a fusion-toggle-has-divider\" style=\"--awb-title-color:var(--awb-color8);--awb-content-color:var(--awb-color8);\"><div class=\"panel-heading\"><h2 class=\"panel-title toggle\" id=\"toggle_debabafcbe112094a\"><a aria-expanded=\"false\" aria-controls=\"debabafcbe112094a\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-1627-2\" data-target=\"#debabafcbe112094a\" href=\"#debabafcbe112094a\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon ec-icon-auge-geschlossen-2\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon ec-icon-auge-offen\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Contergan\/Thalidomide: A Chronology<\/span><\/a><\/h2><\/div><div id=\"debabafcbe112094a\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_debabafcbe112094a\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>Mile\u00adstones from Market Launch to the Current Supply Situation<\/p>\n<p><strong>1954<br><\/strong>Wilhelm Kunz and Hein\u00adrich M\u00fcck\u00adter develop \u201cConter\u00adgan\u201d (known as \u201cK17\u201d) in the research depart\u00adment of Gr\u00fcnen\u00adthal in Stol\u00adberg. In April 1954, thalido\u00admide is filed for a patent with the German Patent Office.&nbsp;<\/p>\n<p><strong>1956<br><\/strong>On June 11, Gr\u00fcnen\u00adthal submits an appli\u00adca\u00adtion for market autho\u00adriza\u00adtion to the North Rhine-Westphalia Ministry of the Inte\u00adrior, which is approved one month later. Start\u00ading in Novem\u00adber, Grippex, a medica\u00adtion contain\u00ading thalido\u00admide, is sold in the Hamburg area. The first child with thalidomide-related birth defects was born in Decem\u00adber. An employee took a sample home and gave it to his&nbsp;wife.&nbsp;<\/p>\n<p><strong>1957<\/strong><br>Conter\u00adgan, contain\u00ading the active ingre\u00addi\u00adent thalido\u00admide, is intro\u00adduced to the market in the Federal Repub\u00adlic of Germany. The sleep aid and seda\u00adtive is avail\u00adable over the counter and is also recom\u00admended for preg\u00adnant women to treat morn\u00ading sick\u00adness. In the years that followed, thalido\u00admide was marketed in numer\u00adous coun\u00adtries, includ\u00ading the United King\u00addom, Australia, Canada, Japan, Austria, and Switzerland.&nbsp;<\/p>\n<p><strong>1958<br><\/strong>Thalido\u00admide is approved and marketed in the United King\u00addom under the name \u201cDistaval\u201d and in Austria \u2013 where it is avail\u00adable only by prescrip\u00adtion \u2013 under the name \u201cSoftenon,\u201d among other coun\u00adtries. In the years that follow, medica\u00adtions contain\u00ading thalido\u00admide are marketed in a total of 48 countries.&nbsp;<\/p>\n<p><strong>1959<br><\/strong>In Janu\u00adary, the first child with birth defects caused by thalido\u00admide is born in Great Britain. A gyne\u00adcol\u00ado\u00adgist informs Gr\u00fcnen\u00adthal of his suspi\u00adcion that his son\u2019s birth defects are linked to thalido\u00admide. Start\u00ading in Octo\u00adber, reports of nerve damage follow\u00ading prolonged use of Contergan\/Thalidomide began to increase. By the end of Novem\u00adber 1961, approx\u00adi\u00admately 1,500 doctors and phar\u00adma\u00adcists, as well as more than 300 consumers, had reported a total of more than 3,000 cases to Gr\u00fcnenthal.&nbsp;<\/p>\n<p><strong>1960<br><\/strong>Distillers, Gr\u00fcnenthal\u2019s licensee in the United King\u00addom, adds a warn\u00ading about nerve damage caused by thalido\u00admide to the Distaval pack\u00adage insert in August 1960. In Octo\u00adber, the KBV alerts the Drug Commis\u00adsion about nerve disor\u00adders caused by thalido\u00admide. In Novem\u00adber, Gr\u00fcnen\u00adthal updates the pack\u00adage insert but asserts that the \u201chyper\u00adsen\u00adsi\u00adtiv\u00adity reac\u00adtions\u201d are reversible. In the U.S., Frances Oldham Kelsey denies approval; the FDA requests addi\u00adtional safety data.&nbsp;<\/p>\n<p><strong>1961<br><\/strong>Warn\u00adings about nerve damage and possi\u00adble birth defects are on the rise. Thalido\u00admide is made avail\u00adable only by prescrip\u00adtion in North Rhine-Westphalia, Hesse, and Baden-W\u00fcrttemberg. However, Bavaria, Berlin, and Lower Saxony failed to ensure that Conter\u00adgan was only avail\u00adable by prescrip\u00adtion before sales were discon\u00adtin\u00adued. On Novem\u00adber 27, Gr\u00fcnen\u00adthal announces that it will with\u00addraw Conter\u00adgan and other thalidomide-containing prod\u00aducts from the market.&nbsp;<\/p>\n<p><strong>1962<\/strong><br>The full extent of the disas\u00adter becomes appar\u00adent: World\u00adwide, approx\u00adi\u00admately 10,000 chil\u00addren are born with severe birth defects; in Germany, about 5,000 are affected. Many of the chil\u00addren die at a young&nbsp;age.&nbsp;<\/p>\n<p><strong>1964<br><\/strong>The \u201cAktion Sorgenkind\u201d lottery (later \u201cAktion Mensch\u201d) is founded. Exten\u00adsive media cover\u00adage breaks the taboo surround\u00ading disabil\u00adity and leads to a shift in perspec\u00adtive: disabil\u00adity is no longer viewed solely as a personal fate, but increas\u00adingly as a soci\u00adetal responsibility.&nbsp;<\/p>\n<p><strong>1968<\/strong><br>The so-called Conter\u00adgan trial against exec\u00adu\u00adtives of the Gr\u00fcnen\u00adthal company begins at the Aachen Regional Court. The first out-of-court settle\u00adments and compen\u00adsa\u00adtion payments for affected indi\u00advid\u00adu\u00adals abroad (e.g., in the United King\u00addom through the distri\u00adb\u00adu\u00adtion part\u00adner Distillers) are reached.&nbsp;<\/p>\n<p><strong>1970<\/strong><br>Gr\u00fcnen\u00adthal reaches a settle\u00adment with the parents of the affected chil\u00addren and agrees to pay 100 million marks. The crim\u00adi\u00adnal proceed\u00adings are dismissed with\u00adout a verdict.&nbsp;<\/p>\n<p><strong>1972<\/strong><br>The orga\u00adni\u00adza\u00adtion now known as the Conter\u00adgan Foun\u00adda\u00adtion is founded under the name \u201cChar\u00adity for Disabled Children.\u201d<\/p>\n<p><strong>1973<br><\/strong>The \u201cThalido\u00admide Children\u2019s Trust\u201d (simi\u00adlar to the Conter\u00adgan Foun\u00adda\u00adtion) is estab\u00adlished in the United Kingdom.<\/p>\n<p><strong>1978<\/strong><br>Follow\u00ading the thalido\u00admide disas\u00adter, a new phar\u00adma\u00adceu\u00adti\u00adcal law goes into effect. The require\u00adments for the safety, qual\u00adity, and effi\u00adcacy of medica\u00adtions are signif\u00adi\u00adcantly tightened.&nbsp;<\/p>\n<p><strong>2005<\/strong><br>The foun\u00adda\u00adtion is renamed the \u201cConter\u00adgan Foun\u00adda\u00adtion for People with Disabilities.\u201d<\/p>\n<p><strong>2010\u20132012<\/strong><br>The so-called Heidel\u00adberg Study exam\u00adines the prob\u00adlems, special needs, and gaps in care faced by people living in Germany with thalidomide-related disabilities.<\/p>\n<p><strong>2013<\/strong><br>The Thalido\u00admide Foun\u00adda\u00adtion Act is amended. Pensions are signif\u00adi\u00adcantly increased, and provi\u00adsions to cover special needs are introduced.&nbsp;<\/p>\n<p><strong>2014<\/strong><br>The estab\u00adlish\u00adment of inter\u00addis\u00adci\u00adpli\u00adnary medical centers of excel\u00adlence is prompted by an expert report from North Rhine-Westphalia on health damage, psychoso\u00adcial impair\u00adments, and care&nbsp;needs.<\/p>\n<p><strong>2016<\/strong><br>The state of North Rhine-Westphalia publishes a research report on its own role in the Contergan-scandal. Barbara Stef\u00adfens, who was health minis\u00adter at the time, apol\u00ado\u00adgizes to those affected for the author\u00adi\u00adties\u2019 failure.&nbsp;<\/p>\n<p><strong>2021<\/strong><br>On the 60th anniver\u00adsary of the drug\u2019s with\u00addrawal from the market, atten\u00adtion is once again focused on the care situ\u00ada\u00adtion for people with thalidomide-related disabil\u00adi\u00adties. Efforts to estab\u00adlish inter\u00addis\u00adci\u00adpli\u00adnary medical centers of excel\u00adlence are continuing.&nbsp;<\/p>\n<p><strong>2023<br><\/strong>The so-called <a href=\"https:\/\/contergan-infoportal.de\/projekte\/gefaessstudie\">Vascu\u00adlar Study<\/a> \u2013 funded by the Conter\u00adgan Foun\u00adda\u00adtion \u2013 is the first study to exam\u00adine vascu\u00adlar and organ patterns in people with thalidomide-related disabil\u00adi\u00adties at the Univer\u00adsity Hospi\u00adtals of Cologne and&nbsp;Ulm.<\/p>\n<p><strong>Today<\/strong><br>Inter\u00adna\u00adtional support for those affected remains inad\u00ade\u00adquate; while the Conter\u00adgan Foun\u00adda\u00adtion was estab\u00adlished in Germany, many victims in other coun\u00adtries are still fight\u00ading for compa\u00adra\u00adble compen\u00adsa\u00adtion. Thalido\u00admide is still used medically today, includ\u00ading for the treat\u00adment of certain cancers and, in some coun\u00adtries, for leprosy. In Brazil, gaps in the health\u00adcare system continue to lead to birth defects in newborns.&nbsp;<\/p>\n<\/div><\/div><\/div><div class=\"fusion-panel panel-default panel-14edcecac3fba3812 fusion-toggle-has-divider\" style=\"--awb-title-color:var(--awb-color8);--awb-content-color:var(--awb-color8);\"><div class=\"panel-heading\"><h2 class=\"panel-title toggle\" id=\"toggle_14edcecac3fba3812\"><a aria-expanded=\"false\" aria-controls=\"14edcecac3fba3812\" role=\"button\" data-toggle=\"collapse\" data-parent=\"#accordion-1627-2\" data-target=\"#14edcecac3fba3812\" href=\"#14edcecac3fba3812\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box active-icon ec-icon-auge-geschlossen-2\" aria-hidden=\"true\"><\/i><i class=\"fa-fusion-box inactive-icon ec-icon-auge-offen\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Association of Thalidomide Victims North Rhine-Westphalia e.V. (Interessenverband Contergangesch\u00e4diger Nordrhein-Westfalen e.V.)<\/span><\/a><\/h2><\/div><div id=\"14edcecac3fba3812\" class=\"panel-collapse collapse \" aria-labelledby=\"toggle_14edcecac3fba3812\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<p>Asso\u00adci\u00ada\u00adtion of Thalido\u00admide Victims North Rhine-Westphalia e.V. (Inter\u00adessen\u00adver\u00adband Conter\u00adgangesch\u00e4di\u00adger Nordrhein-Westfalen e.V.) was founded in Cologne in 1967 by parents of affected chil\u00addren. It was guided by the prin\u00adci\u00adple of self-help: based on the belief that chal\u00adlenges are better over\u00adcome together. The found\u00ading board consisted of Herbert Linn, along with Helene Brosius, Wilhelm Budde, Hans-G\u00fcnter M\u00fcnch, and Helmut Rinner.&nbsp;<\/p>\n<p>Today, the focus is on the long-term effects and the psychoso\u00adcial burdens faced by those affected. Of the approx\u00adi\u00admately 2,400 people in Germany with thalidomide-related disabil\u00adi\u00adties, about 800 live in North Rhine-Westphalia.&nbsp;<\/p>\n<p><strong>Main Respon\u00adsi\u00adbil\u00adi\u00adties of the Association<\/strong><\/p>\n<ul>\n<li><strong>Knowl\u00adedge Shar\u00ading:<\/strong> The advo\u00adcacy group provides infor\u00adma\u00adtion on medical, social, and legal issues to people with thalidomide-related disabil\u00adi\u00adties, their fami\u00adlies, and doctors and ther\u00ada\u00adpists. To this end, it collects rele\u00advant infor\u00adma\u00adtion and presents it in an easy-to-understand, prac\u00adti\u00adcal&nbsp;way.&nbsp;<\/li>\n<li><strong>Every\u00adday and Life Support:<\/strong> The asso\u00adci\u00ada\u00adtion supports its members with ques\u00adtions and chal\u00adlenges related to daily life \u2013 such as acces\u00adsi\u00adble hous\u00ading, orga\u00adniz\u00ading personal assis\u00adtance, or coping with the health conse\u00adquences of thalidomide-related disabilities.<\/li>\n<li><strong>Peer Coun\u00adsel\u00ading:<\/strong> Coun\u00adsel\u00ading provided by those affected for those affected is partic\u00adu\u00adlarly impor\u00adtant. Through direct inter\u00adac\u00adtion, expe\u00adri\u00adenced members help with issues such as pensions and long-term care, or with find\u00ading suit\u00adable doctors and ther\u00ada\u00adpeu\u00adtic services.&nbsp;<\/li>\n<li><strong>Commu\u00adnity and Inter\u00adac\u00adtion:<\/strong> Group meet\u00adings, outings, and events create oppor\u00adtu\u00adni\u00adties for people to come together and inter\u00adact person\u00adally. In this way, the asso\u00adci\u00ada\u00adtion fosters social inter\u00adac\u00adtion and strength\u00adens cohe\u00adsion within the community.&nbsp;<\/li>\n<\/ul>\n<p>The asso\u00adci\u00ada\u00adtion comprises ten local chap\u00adters. It is a member of the Federal Asso\u00adci\u00ada\u00adtion of Conter\u00adgan Victims (Bundesver\u00adband Contergan\u00adgesch\u00e4digter e.V.). <\/p>\n<p><strong>Board of Directors<\/strong><\/p>\n<p>Udo Hert\u00aderich (Chair, Contact Person for Polit\u00adi\u00adcal Affairs)<br>Phone: 0152 \u2013 34 34 25 04<br>Email: herterich@contergan-nrw.eu<\/p>\n<p>Bianca Vogel-Schmidt (Vice Chair, Public Rela\u00adtions Contact)<br>Phone: 02642 \u2013 90 55 37<br>Email: vogel@contergan-nrw.eu<\/p>\n<p>B\u00e4rbel Drohmann (Board Member, Public Rela\u00adtions Contact)<br>Email: drohmann@contergan-nrw.eu<\/p>\n<p>Achim R\u00fcsing (Asset Manager, Contact Person for Account Manage\u00adment and Cashier)<br>Phone: 02327 \u2013 78 87 60<br>Email: ruesing@contergan-nrw.eu<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:100px;width:100%;\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:100px;width:100%;\"><\/div><div class=\"fusion-menu-anchor\" id=\"kontakt\"><\/div><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row fusion-flex-align-items-flex-start fusion-flex-justify-content-center fusion-flex-content-wrap\" style=\"--awb-min-height:undefined;--awb-min-height-medium:undefined;--awb-min-height-small:undefined;--awb-flex-grow:undefined;--awb-flex-grow-medium:undefined;--awb-flex-grow-small:undefined;--awb-flex-shrink:undefined;--awb-flex-shrink-medium:undefined;--awb-flex-shrink-small:undefined;width:104% !important;max-width:104% !important;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-2 fusion_builder_column_inner_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;\"><h2 class=\"fusion-title-heading title-heading-left awb-responsive-type__disable\" style=\"margin:0;\"><strong>Press Contact<\/strong><\/h2><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-3 fusion_builder_column_inner_1_1 1_1 fusion-flex-column fusion-flex-align-self-center\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-2\"><p><b>Udo Hert\u00aderich<br><\/b><\/p>\n<p>Chair\u00adman of the Asso\u00adci\u00ada\u00adtion of Thalido\u00admide Victims North Rhine-Westphalia e.V. (Inter\u00adessen\u00adver\u00adband Conter\u00adgangesch\u00e4di\u00adger Nordrhein-Westfalen e.V.)<\/p>\n<p>Phone: 0152 \u2013 34 34 25 04<br>Email: herterich@contergan-nrw.eu<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":31,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"class_list":["post-1627","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/egmond-circle.eu\/en\/wp-json\/wp\/v2\/pages\/1627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/egmond-circle.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/egmond-circle.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/egmond-circle.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/egmond-circle.eu\/en\/wp-json\/wp\/v2\/comments?post=1627"}],"version-history":[{"count":50,"href":"https:\/\/egmond-circle.eu\/en\/wp-json\/wp\/v2\/pages\/1627\/revisions"}],"predecessor-version":[{"id":2387,"href":"https:\/\/egmond-circle.eu\/en\/wp-json\/wp\/v2\/pages\/1627\/revisions\/2387"}],"wp:attachment":[{"href":"https:\/\/egmond-circle.eu\/en\/wp-json\/wp\/v2\/media?parent=1627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}